Canaccord Genuity Maintains Hold on T2 Biosystems, Raises Price Target to $5
Portfolio Pulse from Benzinga Newsdesk
Canaccord Genuity analyst Kyle Mikson maintains a Hold rating on T2 Biosystems (NASDAQ:TTOO) and raises the price target from $3 to $5.
July 30, 2024 | 11:00 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Canaccord Genuity analyst Kyle Mikson maintains a Hold rating on T2 Biosystems and raises the price target from $3 to $5.
The raised price target from $3 to $5 suggests a positive outlook for T2 Biosystems, which could lead to a short-term increase in stock price. However, the Hold rating indicates that the stock may not outperform the market significantly.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100